Core Viewpoint - The launch of SILKROSE's new product marks a significant milestone in the medical aesthetics industry, showcasing innovative light medical beauty technology and the first domestically produced PEG cross-linked sodium hyaluronate gel with complete independent intellectual property rights [1][8]. Group 1: Product Innovation - The PEG cross-linking technology is highlighted as a key innovation, creating a richer three-dimensional network that enhances product elasticity and prevents displacement and deformation [2][4]. - The safety design of the product is noteworthy, as the PEG fragments released after hyaluronic acid degradation can be completely metabolized in the body, eliminating accumulation risks [4]. - Clinical data indicates that the product's effect can last over 9 months, achieving a balance between "natural dynamism" and "long-lasting safety" [4]. Group 2: Expert Insights - Experts at the event emphasized the broad application prospects of PEG cross-linking technology in the medical aesthetics field, with a focus on technological innovation and product quality [5]. - A roundtable discussion among renowned medical aesthetics experts addressed the comprehensive evaluation system for new technologies and materials in facial rejuvenation treatments, indicating a shift from "incremental competition" to "quality competition" in the light medical beauty market [7]. Group 3: Strategic Partnerships - A strategic cooperation agreement was signed between JianKai Technology and China Resources Shanghai, aiming to leverage channel advantages for accelerated market coverage of the new product [8]. - Since its listing in 2020, JianKai Technology has contributed to the development and production of various PEG-modified drugs and medical devices, both domestically and internationally [8]. Group 4: Market Outlook - With the official launch of SILKROSE and subsequent market promotion, JianKai Technology aims to empower medical beauty institutions through material innovation, fostering a win-win ecosystem for enterprises, institutions, and consumers [10].
SILKROSE 丝玫瑰北京发布会圆满落幕 国内首款自主PEG交联凝胶正式上市